Clinical · Molecular biology
Upfront Comprehensive Genomic Profiling in Advanced Biliary Tract Cancer: Real-World Implementation and Clinical Outcomes
Summary
This real-world study evaluated the implementation of upfront comprehensive genomic profiling (CGP) in 80 patients with advanced biliary tract cancer (BTC). Clinically actionable alterations were detected in 52.5% of cases—predominantly in IDH1, FGFR2, ERBB2, KRAS G12C, and BRAF—with anatomical enrichment of FGFR2 and IDH1 in intrahepatic cholangiocarcinoma. Matched targeted therapies were administered to 11 of the 42 actionable patients, yielding a significantly longer treatment duration compared with the preceding systemic line (p = 0.0391) and enabling secondary surgical resection in two patients. These findings confirm the clinical feasibility and value of upfront CGP in BTC while emphasizing the critical need to bridge the gap between biomarker identification and drug access.
Critical appraisal
Clinical. This real-world cohort (n = 80) demonstrates the clinical utility of upfront CGP, showing significantly longer treatment duration on matched therapy versus the prior systemic line (p = 0.0391) and secondary resectability in 2/14 initially unresectable patients. However, only 26.2% (11/42) of actionable patients received targeted therapy, highlighting a critical implementation gap and supporting streamlined trial enrollment pathways (clinical impact: 1-3 years). BIOMOL: The study demonstrates analytical and pre-analytical feasibility across diverse routine clinical specimens, including cytology (7.5%) and core needle biopsies (47.5%). Molecular findings confirm distinct anatomical sub-profiles, with IDH1 (13.8%) and FGFR2 (8.8%) alterations restricted to intrahepatic cholangiocarcinoma, whereas ERBB2 alterations (5.0%) enriched in extrahepatic and gallbladder cancers, complemented by DDR defects (13.8%) and dMMR/MSI-H (3.8%).
The summary and the appraisal were written by a language model from the title and abstract of the original article. The article was selected automatically by a model, without human review. Methodology